Company Analysis

TherapeuticsMD, Inc. (TXMD)

Nasdaq: TXMD · Pharmaceutical Preparations · Boca Raton, FL · filing with the SEC since 1995
Grade5.5
◀ Past 4.3● Present 6.7▶ Future 5.2
1 est.

Filings

346 filings since 2017 beside 236 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 42 days after the quarter ended. The proxy statement was last filed Nov 3, 2025.

Filings a yearinsider forms included
7773839247182811
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Jan 21, 2026.A late-filing notice, Form NT 10-K, filed Apr 1, 2026.
Insider forms 236

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Aug 11, 2026 10-Q Quarterly report Jun 30, 2026
Aug 11, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Aug 5, 2026 SCHEDULE 13G/A Large holder update, amended
May 12, 2026 10-Q Quarterly report Mar 31, 2026
May 12, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report May 2, 2026
Apr 6, 2026 SCHEDULE 13G Large holder notice
Apr 1, 2026 10-K/A Annual report, amended Dec 31, 2025
Apr 1, 2026 NT 10-K Late annual report notice Dec 31, 2025
Mar 30, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Mar 30, 2026 10-K Annual report Dec 31, 2025
Jan 21, 2026 8-K items 4.01, 9.01 Auditor change · Current report Jan 15, 2026
Dec 16, 2025 8-K item 5.07 Shareholder vote · Current report Dec 15, 2025
Nov 13, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report Nov 12, 2025
Nov 12, 2025 10-Q Quarterly report Sep 30, 2025
Nov 3, 2025 ARS Annual report to shareholders Dec 31, 2024
Nov 3, 2025 DEFA14A Extra proxy material
Nov 3, 2025 DEF 14A Proxy statement Dec 15, 2025
Oct 24, 2025 PRE 14A Preliminary proxy statement
Aug 12, 2025 10-Q Quarterly report Jun 30, 2025
Aug 12, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
May 13, 2025 10-Q Quarterly report Mar 31, 2025
May 13, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Apr 30, 2025 10-K/A Annual report, amended Dec 31, 2024
Apr 9, 2025 8-K item 8.01 Other event · Current report Apr 8, 2025
Mar 27, 2025 10-K Annual report Dec 31, 2024
Mar 27, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Feb 12, 2025 SCHEDULE 13G Large holder notice
Dec 5, 2024 8-K item 5.07 Shareholder vote · Current report
Nov 12, 2024 SC 13G Large holder notice
Nov 12, 2024 10-Q Quarterly report Sep 30, 2024
Nov 12, 2024 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Oct 25, 2024 ARS Annual report to shareholders Dec 31, 2023
Oct 25, 2024 DEFA14A Extra proxy material
Oct 25, 2024 DEF 14A Proxy statement Dec 5, 2024
Sep 20, 2024 8-K item 5.08 item 5.08 · Current report
Aug 12, 2024 10-Q Quarterly report Jun 30, 2024
Aug 12, 2024 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Jun 14, 2024 AW Amendment withdrawal request
May 10, 2024 10-Q Quarterly report Mar 31, 2024
May 10, 2024 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
40 of 346 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton TXMD · research, not advice